You are here

For Journalists

Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.

Please contact:

Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
Mobile: 415.806.6245




Press Releases

September 8, 2015

SAN FRANCISCO, CA—The Gladstone Institutes is pleased to present the inaugural Ogawa-Yamanaka Stem Cell Prize to Masayo Takahashi, MD, PhD, a faculty member and project leader in the Laboratory for Retinal Regeneration at

August 27, 2015

SAN FRANCISCO, CA—Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus’s direct effect on the host’s immune cells, but rather through the cells’ lethal influence on one another.

July 23, 2015

SAN FRANCISCO, CA—The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer’s disease.

July 14, 2015

SAN FRANCISCO, CA—Researchers at the University of California, Berkeley, in collaboration with scientists at the Gladstone Institutes, have developed a template for growing beating cardiac tissue from stem cells, creating a system that could serve as a model for early heart development and a drug-screening tool to make pregnancies safer.

June 24, 2015

SAN FRANCISCO, CA—The Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery opened today at the Gladstone Institutes, as part of a collaboration between Thermo Fisher, Gladstone, the University of California, San Francisco (UCSF), and QB3, to accelerate targeted proteomics research using the most advanced mass spectrometry technologies.

June 18, 2015

SAN FRANCISCO, CA—A new paper out of the iPrEx study—a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men—reported no link between taking Truvada for oral PrEP and experiencing depression.

June 8, 2015

SAN FRANCISCO—Scientists from the Gladstone Institutes and the University of Michigan have identified a cellular mechanism that can be targeted to treat ALS. The researchers revealed that increasing levels of a certain key protein successfully protected against cell death in both genetic and sporadic versions of the disease.

May 11, 2015

SAN FRANCISCO, CA—Scientists have discovered a way to regrow bone tissue using the protein signals produced by stem cells. This technology could help treat victims who have experienced major trauma to a limb, like soldiers wounded in combat or casualties of a natural disaster.

April 30, 2015

SAN FRANCISCO—The Gladstone Institutes was honored to host Japanese Prime Minister Shinzo Abe on Thursday, April 30.

April 27, 2015

SAN FRANCISCO, CA—Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice.